Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Dec;49(12):4974-9.
doi: 10.1128/AAC.49.12.4974-4979.2005.

Lack of effect of experimental hypovolemia on imipenem muscle distribution in rats assessed by microdialysis

Affiliations

Lack of effect of experimental hypovolemia on imipenem muscle distribution in rats assessed by microdialysis

Sandrine Marchand et al. Antimicrob Agents Chemother. 2005 Dec.

Abstract

The aim of this study was to investigate the influence of hypovolemia on the distribution of imipenem in muscle extracellular fluid determined by microdialysis in awake rats. Microdialysis probes were inserted into the jugular vein and hind leg muscle. Imipenem recoveries in muscle and blood were determined in each rat by retrodialysis by drug before drug administration. Hypovolemia was induced by removing 40% of the initial blood volume over 30 min. Imipenem was infused intravenously at a dose of 70 mg . kg(-1) over 30 min, and microdialysis samples were collected for 120 min from hypovolemic (n = 8) and control (n = 8) rats. The decay of the free concentrations in blood and muscle with time were monoexponential, and the concentration profiles in muscle and blood were virtually superimposed in both groups. Accordingly, the ratios of the area under the concentration-time curve (AUC) for tissue (muscle) to the AUC for blood were always virtually equal to 1. Hypovolemia induced a 23% decrease in the clearance (P < 0.05) of imipenem, with no statistically significant alteration of its volume of distribution. This study showed that imipenem elimination was altered in hypovolemic rats, probably due to decreased renal blood flow, but its distribution characteristics were not. In particular, free imipenem concentrations in blood and muscle were always virtually identical.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Relative recovery by loss of IPM (in percent) in blood and muscle tissue estimated before and after hypovolemia after probe perfusion with IPM solution (10 μg · ml−1) at a flow rate of 2 μl · min−1 in a representative rat.
FIG. 2.
FIG. 2.
Unbound IPM concentrations in control rats (n = 8) (left panels) and hypovolemic rats (n = 8) (right panels) after a 30-min intravenous infusion of 70 mg · kg−1 of IPM: superimposed mean concentrations in blood (full circles) and muscle tissue (open circles) in control rats (a1) and hypovolemic rats (a2), mean ± SD concentrations in blood in control rats (b1) and hypovolemic rats (b2), and mean ± SD concentrations in muscle tissue in control (c1) and hypovolemic rats (c2).

References

    1. Araki, H., N. Ogake, R. Tsuneda, S. Minami, Y. Watanabe, I. Tamai, and A. Tsuji. 2002. Muscle distribution of antimicrobial agents after a single intravenous administration to rats. Drug Metab. Pharmacokinet. 17:237-244. - PubMed
    1. Brunner, M., T. Pernerstorfer, B. X. Mayer, H. G. Eichler, and M. Müller. 2000. Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit. Care Med. 28:1754-1759. - PubMed
    1. Chenel, M., S. Marchand, A. Dupuis, I. Lamarche, and W. Couet. 2004. Simultaneous central nervous distribution and pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of norfloxacin administered at a convulsant dose in rats. Br. J. Pharmacol. 142:323-330. - PMC - PubMed
    1. Dalla Costa, T., A. Nolting, A. Kovar, and H. Derendorf. 1998. Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis. J. Antimicrob. Chemother. 42:769-778. - PubMed
    1. Davis, B., and T. Morris. 1993. Physiological parameters in laboratary animals and humans. Pharm. Res. 10:1093-1095. - PubMed

MeSH terms